NanoViricides Inc Share Price OTC Bulletin Board
Equities
US6300871042
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 28.27M 2.22B |
---|---|---|---|---|---|
Net income 2024 * | -8M -628M | Net income 2025 * | -14M -1.1B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-3.29
x | P/E ratio 2025 * |
-2.16
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.69% |
Managers | Title | Age | Since |
---|---|---|---|
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Meeta Vyas
DFI | Director of Finance/CFO | 66 | 12/05/13 |
Jayant Tatake
CTO | Chief Tech/Sci/R&D Officer | - | 02/03/10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Brian Zucker
BRD | Director/Board Member | 62 | 12/11/20 |
Anil Diwan
CEO | Chief Executive Officer | 66 | 31/03/05 |
Director/Board Member | 73 | 06/02/20 |
1st Jan change | Capi. | |
---|---|---|
+11.91% | 114B | |
+11.60% | 105B | |
-4.68% | 23.83B | |
-0.82% | 21.73B | |
-10.12% | 18.1B | |
-42.12% | 16.34B | |
-17.47% | 16.13B | |
+2.77% | 13.75B | |
+34.58% | 11.76B |